Quick Summary

Flaxseed (Linum usitatissimum) is a plant-based source rich in omega-3 polyunsaturated fatty acids, lignans, and soluble fiber. It has been studied for its potential effects on cardiometabolic risk factors such as blood pressure, lipid profiles, glycemic control, insulin resistance, inflammation, and body weight. Clinical evidence suggests flaxseed supplementation may modestly improve blood pressure, body weight, BMI, waist circumference, glycemic control, insulin resistance, and some inflammatory markers. Its use has also been examined in the context of polycystic ovary syndrome (PCOS) metabolic parameters. Safety data indicate it is generally well tolerated. However, further high-quality, large-scale randomized controlled trials are needed to confirm these benefits and clarify optimal dosing, formulation, and safety profiles.

What is it

Flaxseed is the seed of the flax plant (Linum usitatissimum), a member of the Linaceae family. It is valued for its content of alpha-linolenic acid (a plant-based omega-3 fatty acid), lignans (phytoestrogens), and dietary fiber. Flaxseeds can be consumed whole, ground, or as flaxseed oil. The seed and its extracts are used as dietary supplements and in traditional and modern herbal medicine contexts.

Traditional Uses

Traditionally, flaxseed has been used to support digestive health, improve bowel regularity, and maintain cardiovascular health. In some traditional practices, flaxseed is also included in dietary seed cycling approaches intended to influence hormonal balance, such as in managing symptoms related to PMS and PCOS.

Active Compounds

  • Omega-3 fatty acids: Mainly alpha-linolenic acid (ALA)
  • Lignans: Phytoestrogens with antioxidant properties
  • Soluble fiber: Supports gastrointestinal function and metabolic health
  • Other phytochemicals supporting anti-inflammatory and metabolic effects

Potential Benefits with Evidence Levels

  • Blood pressure reduction in patients with cardiovascular risk (Moderate evidence): Systematic reviews and meta-analyses of randomized controlled trials (RCTs) indicate flaxseed supplementation can significantly reduce systolic and diastolic blood pressure by approximately 4 to 9 mmHg (systolic) and 3 to 5 mmHg (diastolic) in individuals with cardiovascular risk factors including hypertension.
  • Improvement in anthropometric indices (body weight, BMI, waist circumference) (Moderate evidence): Meta-analyses have found that flaxseed supplementation may lead to modest reductions in body weight (~0.6 kg), BMI (~0.24 kg/m2), and waist circumference (~1.4 cm), with higher effects observed in longer interventions (10–20 weeks) or individuals with higher BMI.
  • Improvement in glycemic control and insulin resistance in prediabetes and type 2 diabetes (Moderate evidence): Meta-analyses of RCTs show flaxseed supplementation can significantly reduce fasting blood glucose, HbA1c, insulin concentrations, and insulin resistance indices such as HOMA-IR in adults with prediabetes and type 2 diabetes.
  • Reduction of inflammatory markers and triglycerides in coronary artery disease (Moderate evidence): Flaxseed supplementation has been observed to significantly decrease triglycerides, high-sensitivity C-reactive protein, and fasting blood glucose in patients with coronary artery disease, although effects on other lipid parameters are inconsistent.
  • Potential benefits in polycystic ovary syndrome (PCOS) and premenstrual syndrome (PMS) via seed cycling (Insufficient/preliminary evidence): Small clinical studies suggest dietary seed cycling including flaxseed may improve hormonal profiles, menstrual regularity, and symptom severity in PCOS and PMS. These findings are limited and require further well-designed trials.
  • Adipokine modulation (Low to moderate evidence): Flaxseed supplementation is associated with a reduction in leptin levels but shows no consistent effect on adiponectin levels based on available meta-analyses.

Side Effects

Flaxseed is generally well tolerated in clinical trials. No consistent or serious adverse effects have been reported. However, quality control and purity of flaxseed products vary, and potential contamination or variable composition exists, which could affect tolerability or safety.

Drug Interactions

One randomized controlled crossover trial reported no significant pharmacokinetic interaction between flaxseed and the oral anticoagulant dabigatran. However, broader data on herb-drug interactions with flaxseed are limited. Caution is recommended when using flaxseed in combination with anticoagulant or antiplatelet medications due to possible additive effects.

Who Should Avoid It

No specific contraindications have been definitively identified in clinical studies. However, safety classification reviews of herbal medicines for hypertension advise caution regarding dosing and use in individuals with certain health conditions. Flaxseed use during pregnancy and breastfeeding should be approached cautiously due to limited safety data, and it is recommended to consult a healthcare professional before use.

Evidence Limitations

Most human clinical evidence on flaxseed is derived from small to moderate-sized RCTs of varying duration, with heterogeneity in doses, formulations (whole seed, ground seed, oil, lignans), and participant characteristics. Quality control of flaxseed products, potential contamination, and lack of blinding were noted limitations. Larger, well-designed, adequately powered trials with standardized interventions are needed to confirm effects and long-term safety, including in special populations. Long-term clinical outcomes remain underexplored.

References

Last Reviewed

April 2024

Disclaimer: This information is provided for educational purposes only and does not constitute medical advice. Consult a healthcare professional before starting any new dietary supplement, especially if you have underlying health conditions or are taking medications.